334
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis

, MD
Pages 91-102 | Published online: 19 Jan 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

E. Ridolo, M. Caminati, I. Martignago, V. Melli, C. Salvottini, O. Rossi, A. Dama, M. Schiappoli, C. Bovo, C. Incorvaia & G. Senna. (2016) Allergic rhinitis: pharmacotherapy in pregnancy and old age. Expert Review of Clinical Pharmacology 9:8, pages 1081-1089.
Read now

Articles from other publishers (11)

Christiane Dings, Peter Meiser, Frank Holzer, Michael Flegel, Dominik Selzer, Eszter Nagy, Ralph Mösges, Jens Peter Klussmann & Thorsten Lehr. (2022) Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients. Pharmaceutics 14:10, pages 2059.
Crossref
Junhu Tai, Munsoo Han, Dabin Lee, Il-Ho Park, Sang Hag Lee & Tae Hoon Kim. (2022) Different Methods and Formulations of Drugs and Vaccines for Nasal Administration. Pharmaceutics 14:5, pages 1073.
Crossref
Cemal Cingi, Nuray Bayar Muluk, Dimitrios I. Mitsias, Nikolaos G. Papadopoulos, Ludger Klimek, Anu Laulajainen-Hongisto, Maija Hytönen, Sanna Katriina Toppila-Salmi & Glenis Kathleen Scadding. (2021) The Nose as a Route for Therapy: Part 1. Pharmacotherapy. Frontiers in Allergy 2.
Crossref
Mark S. Dykewicz, Dana V. Wallace, David J. Amrol, Fuad M. Baroody, Jonathan A. Bernstein, Timothy J. Craig, Chitra Dinakar, Anne K. Ellis, Ira Finegold, David B.K. Golden, Matthew J. Greenhawt, John B. Hagan, Caroline C. Horner, David A. Khan, David M. Lang, Desiree E.S. Larenas-Linnemann, Jay A. Lieberman, Eli O. Meltzer, John J. Oppenheimer, Matthew A. Rank, Marcus S. Shaker, Jeffrey L. Shaw, Gary C. Steven, David R. Stukus, Julie Wang, Mark S. Dykewicz, Dana V. Wallace, Chitra Dinakar, Anne K. Ellis, David B.K. Golden, Matthew J. Greenhawt, Caroline C. Horner, David A. Khan, David M. Lang, Jay A. Lieberman, John J. Oppenheimer, Matthew A. Rank, Marcus S. Shaker, David R. Stukus, Julie Wang, Mark S. Dykewicz, Dana V. Wallace, David J. Amrol, Fuad M. Baroody, Jonathan A. Bernstein, Timothy J. Craig, Ira Finegold, John B. Hagan, Desiree E.S. Larenas-Linnemann, Eli O. Meltzer, Jeffrey L. Shaw & Gary C. Steven. (2020) Rhinitis 2020: A practice parameter update. Journal of Allergy and Clinical Immunology 146:4, pages 721-767.
Crossref
Annabelle M. Watts, Allan W. Cripps, Nicholas P. West & Amanda J. Cox. (2019) Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers With Topical Pharmaceutical Agents. Frontiers in Pharmacology 10.
Crossref
Flavia C.L. Hoyte & Rohit K. Katial. (2011) Antihistamine Therapy in Allergic Rhinitis. Immunology and Allergy Clinics of North America 31:3, pages 509-543.
Crossref
KATHLEEN PILLSBURY RUTLEDGE, CARRIE D'ANDREA, WILLIAM J. WHEELER & HARRY J. SACKS. (2011) SENSORY STUDY OF A NEW FORMULATION OF AZELASTINE NASAL SPRAY WITH REDUCED BITTERNESS. Journal of Sensory Studies 26:1, pages 35-39.
Crossref
Jayant M Pinto & Seema Jeswani. (2010) Rhinitis in the geriatric population. Allergy, Asthma & Clinical Immunology 6:1.
Crossref
Jonathan M. HorbalJonathan A. Bernstein. (2010) Azelastine HCl: A Review of the Old and New Formulations. Clinical Medicine Insights: Therapeutics 2, pages CMT.S3865.
Crossref
Michael A. Kaliner. (2009) Azelastine and olopatadine in the treatment of allergic rhinitis. Annals of Allergy, Asthma & Immunology 103:5, pages 373-380.
Crossref
Jonathan A. Bernstein, Bruce Prenner, Berrylin J. Ferguson, Jay Portnoy, William J. Wheeler & Harry J. Sacks. (2009) Double-Blind, Placebo-Controlled Trial of Reformulated Azelastine Nasal Spray in Patients with Seasonal Allergic Rhinitis. American Journal of Rhinology & Allergy 23:5, pages 512-517.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.